Structure and in vivo function of Hsp90

Current Opinion in Structural Biology

Volumn 10, Issue 1, 2000, Pages 46-51

  Pearl, Laurence H ^a   Prodromou, Chrisostomos ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHAPERONE; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; HERBIMYCIN A; RADICICOL;

DRUG PROTEIN BINDING; DRUG TARGETING; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0033951278     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(99)00047-0     Document Type: Review

References (50)

1. Pratt W.B. The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc Soc Exp Biol Med. 217:1998;420-434.
2. Prodromou C., Roe S.M., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. Identification and structural characterisation of the ATP/ADP binding site in the Hsp90 molecular chaperone. Cell. 90:1997;65-75.
3. Grenert J.P., Sullivan W.P., Fadden P., Haystead T.A.J., Clark J., Mimnaugh E., Krutzsch H., Ochel H-J., Schulte T.W., Sausville E.et al. The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J Biol Chem. 272:1997;23843-23850.
4. Panaretou B., Prodromou C., Roe S.M., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J. 17:1998;4829-4836. This paper provides the first demonstration that Hsp90 both binds and hydrolyses ATP, and that mutations in the ATP-binding site that abolish these properties in vitro abolish yeast Hsp90's essential functions in vivo.
5. Obermann W.M.J., Sondermann H., Russo A.A., Pavletich N.P., Hartl F.U. In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. J Cell Biol. 143:1998;901-910. A second demonstration of the in vivo dependence of Hsp90 function on ATPase activity.
6. Grenert J.P., Johnson B.D., Toft D.O. The importance of ATP binding and hydrolysis by Hsp90 in formation and function of protein heterocomplexes. J Biol Chem. 274:1999;17525-17533. The first demonstration in vitro that the activation of an authentic Hsp90-dependent client protein, progesterone receptor, to a functional state in vitro is dependent on the functional ATPase activity of Hsp90.
7. Prodromou C., Roe S.M., Piper P.W., Pearl L.H. A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone. Nat Struct Biol. 4:1997;477-482.
8. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. The structural basis for inhibition of the Hsp90 molecular chaperone, by the anti-tumour antibiotics radicicol and geldanamycin. J Med Chem. 42:1999;260-266. This paper describes crystal structures of the N-terminal domain of yeast Hsp90 in complexes with geldanamycin and radicicol, compares them with complexes with bound ATP/ADP and defines key pharmacophores for future drug development.
9. Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U., Pavletich N.P. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell. 89:1997;239-250.
10. Ban C., Yang W. Crystal structure and ATPase activity of MutL: implications for DNA repair and mutagenesis. Cell. 95:1998;541-552.
11. Ban C., Junop M., Yang W. Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair. Cell. 97:1999;85-97. This paper describes the crystal structure of MutL bound to an ATP analogue. It provides a valuable assessment of the common structural and functional characteristics of the GyrB-Hsp90-MutL family of N-terminal ATPase domains.
12. Bilwes A.M., Alex L.A., Crane B.R., Simon M.I. Structure of CheA, a signal-transducing histidine kinase. Cell. 96:1999;131-141.
13. Maruya M., Sameshima M., Nemoto T., Yahara I. Monomer arrangement in HSP90 dimer as determined by decoration with N and C-terminal region specific antibodies. J Mol Biol. 285:1999;903-907. An electron microscopy study of Hsp90 that shows direct evidence for the association of N-terminal domains within an Hsp90 dimer following heat shock and, possibly, ATP binding.
14. Kampranis S.C., Bates A.D., Maxwell A. A model for the mechanism of strand passage by DNA gyrase. Proc Natl Acad Sci USA. 96:1999;8414-8419.
15. Dittmar K., Pratt W.B. Folding of the glucocorticoid receptor by the reconstituted hsp90-based chaperone machinery. J Biol Chem. 272:1997;13047-13054.
16. Kosano H., Stensgard B., Charlesworth M.C., McMahon N., Toft D. The assembly of progesterone receptor-hsp90 complexes using purified proteins. J Biol Chem. 273:1998;32973-32979.
17. Das A.K., Cohen P.T.W., Barford D. The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions. EMBO J. 17:1998;1192-1199. The authors describe the first crystal structure of a TPR domain, revealing a channel for peptide binding.
18. Russell L.C., Whitt S.R., Chen M-S., Chinkers M. Identification of conserved residues required for the binding of a tetratricopeptide repeat domain to heat shock protein 90. J Biol Chem. 274:1999;20060-20063. This mutagenesis study shows the importance of basic residues within the TPR domain groove and acidic residues in the C terminus of Hsp90 in mediating Hsp90-TPR-containing co-chaperone interactions.
19. Carrello A., Ingley E., Minchin R.F., Tsai S., Ratajczak T. The common tetratricopeptide repeat acceptor site for steroid receptor associated immunophilins and hop is located in the dimerization domain of Hsp90. J Biol Chem. 274:1999;2682-2689.
20. Chen S.Y., Sullivan W.P., Toft D.O., Smith D.F. Differential interactions of p23 and the TPR-containing proteins Hop, Cyp40, FKBP52 and FKBP51 with Hsp90 mutants. Cell Stress Chaperones. 3:1998;118-129. Mutational analysis of Hsp90 showed its C-terminal region to be essential for TPR-domain-containing co-chaperone binding.
21. •]).
22. Prodromou C., Siligardi G., O'Brien R., Woolfson D.N., Regan L., Panaretou B., Ladbury J.E., Piper P.W., Pearl L.H. Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones. EMBO J. 18:1999;754-762. The TPR-containing co-chaperone p60/Hop/Sti1 was shown to inhibit the ATPase activity of Hsp90 and produce significant conformational change on binding. This study also provides the first direct measurement of the stoichiometry of TPR-containing co-chaperone binding to Hsp90, revealing two TPR-binding sites per Hsp90 dimer, rather than one (as previously thought).
23. •], reports the discovery of the first essential TPR-containing co-chaperone and the existence of a Cns1-Hsp90-Cpr7 complex. This latter discovery suggests the presence of two TPR-binding sites per Hsp90 dimer.
24. •].
25. Grammatikakis N., Lin J-H., Grammatikakis A., Tsichlis P.N., Cochran B.H. p50cdc37 acting in concert with Hsp90 is required for Raf-1 function. Mol Cell Biol. 19:1999;1661-1672.
26. Silverstein A.M., Grammatikakis N., Cochran B.H., Chinkers M., Pratt W.B. P50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. J Biol Chem. 273:1998;20090-20095.
27. Chen S., Smith D.F. Hop as an adaptor in the heat shock protein 70 (Hsp70) and Hsp90 chaperone machinery. J Biol Chem. 273:1998;35194-35200.
28. Johnson B.D., Schumacher R.J., Ross E.D., Toft D.O. Hop modulates hsp70/hsp90 interactions in protein folding. J Biol Chem. 273:1998;3679-3686.
29. Fang Y., Fliss A.E., Rao J., Caplan A.J. SBA1 encodes a yeast Hsp90 cochaperone that is homologous to vertebrate p23 proteins. Mol Cell Biol. 18:1998;3727-3734.
30. •]) was identified in a different genetic screen with Hsp90 ts mutants, which also identified Hch1 - a new non-TPR-containing co-chaperone.
31. Duina A.A., Marsh J.A., Kurtz R.B., Chang H-C.J., Lindquist S., Gaber R.F. The peptidyl-prolyl isomerase domain of the Cyp-40 cyclophilin homolog Cpr7 is not required to support growth or glucocorticoid receptor activity in Saccharomyces cerevisiae. J Biol Chem. 273:1998;10819-10822.
32. Pratt W.B., Dittmar K.D. Studies with purified chaperones advance the understanding of the mechanism of glucocorticoid receptor hsp90 heterocomplex assembly. Trends Endocrinol Metabol. 9:1998;244-252.
33. Caamano C.A., Morano M.I., Dalman F.C., Pratt W.B., Akil H. A conserved proline in the hsp90 binding region of the glucocorticoid receptor is required for hsp90 heterocomplex stabilization and receptor signalling. J Biol Chem. 273:1998;20473-20480.
34. Xu M., Dittmar K.D., Giannoukos G., Pratt W.B., Simons S.S. Binding of hsp90 to the glucocorticoid receptor requires a specific 7-amino acid sequence at the amino terminus of the hormone-binding domain. J Biol Chem. 273:1998;13918-13924.
35. Xu Y., Singer M.A., Lindquist S. Maturation of the tyrosine kinase c Src as a kinase and as a substrate depends on the molecular chaperone Hsp90. Proc Natl Acad Sci USA. 96:1999;109-114. An in vivo study that demonstrates conclusively that, as for oncogenic v-Src, the activation of normal cellular Src kinase (and probably other Src-family kinases) is Hsp90-dependent.
36. Hartson S.D., Ottinger E.A., Huang W., Barany G., Burn P., Matts R.L. Modular folding and evidence for phosphorylation-induced stabilization of an Hsp90-dependent kinase. J Biol Chem. 273:1998;8475-8482.
37. Loo M.A., Jensen T.J., Cui L., Hou Y-X., Chang X-B., Riordan J.R. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteosome. EMBO J. 17:1998;6879-6887.
38. Garcia-Cardena G., Fan R., Shah V., Sorrentino R., Cirino G., Papapetropoulos A., Sessa W.C. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 392:1998;821-824.
39. Holt S.E., Aisner D.L., Baur J., Tesmer V.M., Dy M., Ouellette M., Trager J.B., Morin G.B., Toft D.O., Shay J.W.et al. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev. 13:1999;817-826.
40. Hoshino T., Wang J., Devetten M.P., Iwata N., Kajigaya S., Wise R.J., Liu J.M., Youssoufian H. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression. Blood. 91:1998;4379-4386.
41. Zou J.Y., Guo Y.L., Guettouche T., Smith D.F., Voellmy R. Repression of heat shock transcription factor HSF1 activation by Hsp90 (Hsp90 complex) that forms a stress-sensitive complex with HSF1. Cell. 94:1998;471-480. Hsp90 is shown to have a direct role in the regulation of the heat-shock response. It forms a complex with the heat-shock transcription factor HSF1 and maintains it in a monomeric inactive form, which is released on heat shock.
42. Ali A., Bharadwaj S., O'Carroll R., Ovsnek N. Hsp90 interacts with and regulates the activity of heat shock factor 1 in Xenopus oocytes. Mol Cell Biol. 18:1998;4949-4960.
43. Duina A.A., Kalton H.M., Gaber R.F. Requirement for Hsp90 and a CyP-40-type cyclophilin in negative regulation of the heat shock response. J Biol Chem. 273:1998;18974-18978.
44. Rutherford S.L., Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature. 396:1998;336-342. The impairment of Hsp90 function produces dramatic changes in the morphological development of Drosophila, revealing cryptic genetic variation whose phenotypes are suppressed by Hsp90, thus assisting the maintenance of 'wild-type' structure and function.
45. Whitesell L., Mimnaugh E.G., Decosta B., Myers C.E., Neckers L.M. Inhibition of heat-shock protein Hsp90-Pp60(V-Src) heteroprotein complex-formation by benzoquinone ansamycins - essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci USA. 91:1994;8324-8328.
46. Sharma S.V., Agatsuma T., Nakano H. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol. Oncogene. 16:1998;2639-2645.
47. Soga S., Kozawa T., Narumi H., Akinaga S., Irie K., Matsumoto K., Sharma S.V., Nakano H., Mizukami T., Hara M. Radicicol leads to selective depletion of Raf kinase and disrupts K-Ras-activated aberrant signaling pathway. J Biol Chem. 273:1998;822-828.
48. Whitesell L., Sutphin P.D., Pulcini E.J., Martinez J.D., Cook P.H. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol. 18:1998;1517-1524.
49. Schulte T.W., Akinaga S., Soga S., Sullivan W., Stensgard B., Toft D., Neckers L.M. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin. Cell Stress Chaperones. 3:1998;100-108.
50. Scheibel T., Weikl T., Buchner J. Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence. Proc Natl Acad Sci USA. 95:1998;1495-1499.